CHEK2 and breast cancer: Targeted gene sequencing analyses identified other CHEK2 variants in FC BC cases, with c.1217G > A; p.Arg406His being the most promising candidate based on our in silico analysis (Table 2, Table S3), though the carrier frequencies were not significantly different between BC cases and controls [135].